Archangels
VC Fund
Edinburgh, United Kingdom
Archangels is a VC fund in Edinburgh focused on Software and Health Care. Originally formed in 1992 and based in Edinburgh, Archangels is a prominent business angel syndicate which has been at the forefront of early stage investing in Scotland for more than two decades. Today, Archangels comprises more than 60 investor members and typically co-ordinates the investment of more than £10 million per year in early stageScottish companies.Their business ethos is underpinned by four fundamental pillars, which are to:- Give something back- Help young Scottish companies- Generate attractive investment returns, and- Have funThe Archangels syndicate predominantly invests in companies from the technology, software and life sciences sectors – three markets in which Scotland produces a wealth of talent. The syndicate and its executive team have wide experience in diverse business sectors and disciplines to help and support the creation and development of young companies to maximise investor return.
- Total investments:
- 85
- Last investment:
- Lead investor:
- 54%
Last updated:
For AI agents: llms.txt
Industries Archangels invests in
Stages Archangels invests in
Countries Archangels invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.3M–$3.9M
- Series A
- $1.6M–$8.3M
Investment Focus
Industry
- Software 12 (14%)
- Health Care 11 (13%)
- Biotechnology 11 (13%)
- Medical 7 (8%)
- Medical Device 7 (8%)
Stage
- Funding Round 24 (28%)
- Seed 11 (13%)
- Series A 11 (13%)
- Venture - Series Unknown 11 (13%)
- Angel 3 (4%)
Country
- United Kingdom 38 (45%)
- United States 3 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
David Ovens
Joint Managing Director
|
Joint Managing Director | Total investments: 6 | Find email | |
Eric Young
Chairman
|
Chairman | Total investments: 0 | Find email | |
Gavin Gemmell
Chairman
|
Chairman | Total investments: 0 | Find email | |
Lindsay Miller
Office Manager
|
Office Manager | Total investments: 0 | Find email | |
Shaolei McKie
Investment Executive
|
Investment Executive | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Bioliberty are a medtech start-up developing rehabilitation solutions for degenerative and traumatic conditions. | $8.3M / Series A / Mar 18, 2026 | ||
| Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools. | $8M / Series A / Mar 18, 2026 | ||
BioCaptiva
|
BioCaptiva develops liquid biopsy technology devices to diagnose and monitoring to detect cancers. | $2.1M / Venture - Series Unknown / Mar 09, 2026 | |
1inhaler
|
1inhaler operates as a developer of drug delivery device. | $2M / Seed / Nov 17, 2025 | |
| CSignum specializes in wireless communications solutions, digitization of subsea assets, and actionable insights for ocean industries. | $8M / Series A / Apr 22, 2025 | ||
| Neuranics is a company that creates magnetic sensors that are integrated with semiconductor technology for use in health, fitness, and metaverse applications. Neuranics' proprietary technology detects tiny magnetic impulses from organs of the body using scalable spintronics sensors powered by semiconductors. According to the business, thetechnology could solve the current inadequacies of health monitoring equipment and human-machine interfaces. | $8M / Seed / Apr 09, 2025 | ||
| Cytomos® develops and provides integrated, predictive analytics systems for intelligent bioprocessing in biopharma and cell therapy domains. Built upon our patented Cytomos® Dielectric Spectroscopy (CDS™) technology, our systems are unbiased, have single-cell resolution and are scalable across all upstream production stages. Leveraging theunmatched data depth per cell provided by CDS™, our proprietary machine learning (ML) algorithms provide insights into your bioprocesses like never before. | $6.3M / Venture - Series Unknown / Nov 19, 2024 | ||
| Administrate is a comprehensive, configurable training management platform that helps organizations streamline enterprise learning and development. Organize, deliver, plan, automate, analyze, and scale your training program effectively -- all through one system. Deliver multi-modality learner experiences, maximize training resources, anddemonstrate business results with insight-rich reporting. Hundreds of organizations serving millions of learners choose Administrate to manage their training program. | $4M / Venture - Series Unknown / Aug 19, 2024 | ||
| Integrated Graphene develops innovative manufacturing process that enables the company to produce high performing, pure, 3D graphene (3DG) foam directly onto any surface, at room temperature and in seconds. | $11.2M / Venture - Series Unknown / Jun 18, 2024 | ||
| Lumie researchs, develops, and design light therapy product for seasonal affective disorder & better sleep. | $12.5M / Venture - Series Unknown / May 01, 2024 | ||
| See all 85 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Archangels invest in?
Archangels invests primarily in Software, Health Care and Biotechnology startups, most often at Funding Round and Seed stage. Most of the 85 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Archangels's check size?
Archangels typically joins rounds of $1.3M–$3.9M at Seed and $1.6M–$8.3M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Archangels participates in.
How do I contact Archangels?
Public channels for Archangels include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Archangels?
The team at Archangels includes David Ovens (Joint Managing Director), Eric Young (Chairman) and Gavin Gemmell (Chairman). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
